An Introduction to COVID-19
On March 11th 2020 the World Health Organization declared COVID-19 a pandemic. The impact on the medical community has been huge, not only on the front-line but also those navigating patient treatment during this unprecedented situation.
The touchRESPIRATORY expert faculty have been sharing their experiences and advice during this challenging time through video interviews and short articles.
Our supporting partners do not constitute an endorsement of the content on this page.
Considering the Impact of Type 2 Diabetes Mellitus—Biological Mechanisms in COVID-19 Pathology
US Respiratory and Pulmonary Diseases. 2020;5(1):24-7 DOI: https://doi.org/10.17925/USPRD.2020.5.1.24
The COVID-19 pandemic has infected more than 61 million people and led to more than 1 million deaths worldwide.1 The USA was one of the later countries to experience large scale community transmission; to date, there have been 13.2 million cases and approaching 300,000 deaths attributed to COVID-19.1 The USA has the highest overall deaths globally.1,2 The COVID-19 […]
Impact of Smoking and Tobacco use on the Severity of COVID-19 Infection
US Respiratory and Pulmonary Diseases. 2020;5(1):12-4 DOI: https://doi.org/10.17925/USPRD.2020.5.1.12
Smoking is a significant risk factor for severe COVID-19. A substantial amount of evidence supports the fact that tobacco use and chronic obstructive pulmonary disease (COPD) are among the strongest risk factors that lead to severe disease and high mortality due to COVID-19 illness. In a recent publication, Zhao et al. carried out a meta-analysis […]
COVID-19 Pandemic—Allergen-specific Immunotherapy Positioning in Respiratory Allergy
US Respiratory & Pulmonary Diseases. 2020;5(1):10-1 DOI: https://doi.org/10.17925/USPRD.2020.5.1.10
Globally, the coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has infected in excess of 55 million people and is associated with over 1.3 million deaths to date (European Centre for Disease Prevention and Control data).1 COVID-19 is placing significant strain on all aspects of routine healthcare and has raised […]
Julie Ake, CHEST 2020 – Vaccine Candidates for COVID-19
Following her presentation at CHEST 2020, entitled ‘Current Vaccine Candidates for COVID-19: Preclinical and Clinical Data’, Julie Ake (Walter Reed Army Institute of Research, Silver Spring, MD, USA) talks to touchRESPIRATORY further about vaccines in development for COVID-19. Questions What different vaccine platforms are currently being investigated for COVID-19? (0.12) How are clinical trials being harmonised and accelerated for rapid vaccine development? […]
Ivan Gentile, ERS 2020 – Outcome Prediction in COVID-19 Patients
Following the ERS International Congress, we were delighted to catch up with Prof. Ivan Gentile to further discuss the topic of his presentation entitled ‘Severity Assessment and Outcome Prediction in COVID-19 Patients‘. Questions 1. Why do levels of C-reactive protein (CRP) increase during COVID-19? (0:20) 2. How can CRP testing inform severity assessment and outcome […]
Sara De Matteis, ERS 2020 – Air Pollution and COVID-19 Mortality
We discuss with Prof. Sara De Matteis (University of Cagliari, Cagliari, Italy) what we know so far about the potential association between air pollution exposure and SARS-CoV-2 infection. Questions 1. Could you give us a brief overview of the potential association between air pollution exposure and SARS-CoV-2 infection? (0:34) 2. What is the biological plausibility […]
Filippos Filippidis, ERS 2020 – Smoking as a Risk Factor for COVID-19 Infection and Severe Disease
We discuss with Dr. Filippos Filippids (Imperial College London, London, UK) what the literature has shown us so far about the link between smoking and COVID-19 disease. Questions 1. What do we know so far about COVID-19 and smoking? (0:10) 2. What are the current challenges and limitations of research into the impact of smoking […]
Tobias Welte, ERS 2020 – COVID-19 Vaccines and Early Trials
It was a pleasure to meet with Prof. Tobias Welte (Medizinische Hochschule, Hannover, Germany), following his keynote presentation, to continue the discussion around COVID-19 management, current vaccine approaches and promising agents in clinical development. Questions 1. What are the major obstacles to be overcome in the investigation of management and preventative strategies for COVID-19? (0:37) […]
Jennifer Taylor-Cousar, April 2020 – COVID-19 and Cystic Fibrosis
Dr Jennifer Taylor-Cousar (National Jewish Health, Denver, CO, USA) explores what we have learnt so far about how COVID-19 is effecting patients with cystic fibrosis. Questions 1. What is the risk to cystic fibrosis patients from COVID-19 and what have we learned from reported cases so far? (0:07) 2. It seems that, to date, cystic […]
Journal articles and more to your inbox
Get the latest clinical insights from touchRESPIRATORYSign me up!